Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study
Crossref DOI link: https://doi.org/10.1186/s12872-016-0361-9
Published Online: 2016-10-22
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huo, Y.
Jing, Z. C.
Zeng, X. F.
Liu, J. M.
Yu, Z. X.
Zhang, G. C.
Li, Y.
Wang, Y.
Ji, Q. S.
Zhu, P.
Wu, B. X.
Zheng, Y.
Wang, P. P.
Li, J.
License valid from 2016-10-22